Department of Pharmacology and Therapeutics, Faculty of Medicine, University of Manitoba, 753 McDermot Avenue, Winnipeg, MB R3E 0T6, Canada.
Can J Physiol Pharmacol. 2009 Oct;87(10):873-82. doi: 10.1139/Y09-079.
Absence of meal-induced insulin sensitization (AMIS) results in a predictable progression of dysfunctions, including postprandial hyperglycemia, compensatory hyperinsulinemia, resultant hyperlipidemia, increased oxidative stress, and obesity, progressing to syndrome X and diabetes. To test the 'AMIS syndrome' hypothesis we used 3 known means of producing graded and progressive changes in meal-induced insulin sensitization in rats. We used an aging model (9, 26, and 52 weeks), associated with a slow development of AMIS; a low-dose sucrose supplement model to accelerate the development of AMIS; and an antioxidant cocktail (S-adenosylmethionine, vitamin E, and vitamin C) to protect against the effect of the sucrose on meal-induced insulin sensitization. Adiposity was assessed from weighed regional fat masses and bioelectrical impedance. AMIS developed with age, was increased by sucrose supplementation, and was inhibited by the antioxidant cocktail. AMIS correlated with postprandial hyperglycemia, hyperinsulinemia, hyperlipidemia, and with adiposity (r2 = 0.7-0.8) regardless of age or nutrient status. The range of degrees of AMIS, established over time with these models, afforded the tool with which to test the AMIS syndrome and further the argument that AMIS is the first metabolic defect that cumulatively leads to a predictable series of homeostatic disturbances and dysfunctions, including obesity and type 2 diabetes.
缺乏进食诱导的胰岛素敏感性(AMIS)会导致一系列可预测的功能障碍,包括餐后高血糖、代偿性高胰岛素血症、随之而来的血脂异常、氧化应激增加和肥胖,进而发展为代谢综合征和糖尿病。为了验证“AMIS 综合征”假说,我们使用了 3 种已知的方法来在大鼠中产生逐渐和渐进的进食诱导的胰岛素敏感性变化。我们使用了一个老化模型(9、26 和 52 周),该模型与 AMIS 的缓慢发展有关;低剂量蔗糖补充模型加速 AMIS 的发展;抗氧化鸡尾酒(S-腺苷甲硫氨酸、维生素 E 和维生素 C)用于抵抗蔗糖对进食诱导的胰岛素敏感性的影响。脂肪量通过称重的区域性脂肪量和生物电阻抗来评估。随着年龄的增长,AMIS 逐渐发展,蔗糖补充会增加 AMIS,而抗氧化鸡尾酒会抑制 AMIS。AMIS 与餐后高血糖、高胰岛素血症、血脂异常以及肥胖(r2 = 0.7-0.8)相关,无论年龄或营养状况如何。这些模型随着时间的推移建立的 AMIS 程度范围为测试 AMIS 综合征提供了工具,并进一步证明 AMIS 是导致一系列可预测的内稳态紊乱和功能障碍的第一个代谢缺陷,包括肥胖和 2 型糖尿病。